|
⚲
|
| Keyboard |
| Lynx1 Capital Management LP | |
|---|---|
| Firm | Lynx1 Capital Management LP |
| Address | D81 Calle C, Suite 301, Pmb 1202 Suite 200, Pmb 1237 Dorado, PR 00646-2051 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | |||||
| Lynx1 Master Fund LP | 021-514752 | Promoter | 114.0 M | 576.8 M | |
| Lynx1 Onshore Fund LP | 021-409871 | Promoter | 176.2 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
TScan Therapeutics Inc TCRX
Common Stock
|
2025-12-23 | Buy | 6,232 | $0.90 | 5,609 |
|
TScan Therapeutics Inc TCRX
Common Stock
|
2025-12-22 | Buy | 75,500 | $0.90 | 67,950 |
|
TScan Therapeutics Inc TCRX
"Common stock, $0.0001 par value per share (""Common Stock"")"
|
2025-12-19 | Buy | 80,069 | $0.90 | 72,062 |
|
Cullinan Therapeutics Inc CGEM
Common stock, $0.0001 par value per share
|
2025-10-28 | Buy | 165,667 | $8.40 | 1,391,603 |
|
Bionomics Limited/Fi NEUP
Common stock, $0.00001 par value per share
|
2025-10-21 | Buy | 639,110 | $5.14 | 3,285,025 |
|
Cullinan Therapeutics Inc CGEM
Common Stock
|
2025-10-17 | Buy | 32,217 | $7.84 | 252,581 |
|
Cullinan Therapeutics Inc CGEM
Common Stock
|
2025-10-16 | Buy | 150,000 | $8.86 | 1,329,000 |
|
Cullinan Therapeutics Inc CGEM
Common Stock
|
2025-10-15 | Buy | 51,500 | $7.94 | 408,910 |
|
Cullinan Therapeutics Inc CGEM
"Common stock, $0.0001 par value per share (""Common Stock"")"
|
2025-10-14 | Buy | 15,032 | $7.59 | 114,093 |
|
Cullinan Therapeutics Inc CGEM
Common Stock
|
2025-10-10 | Buy | 277,298 | $7.36 | 2,040,913 |
|
Cullinan Therapeutics Inc CGEM
Common Stock
|
2025-10-09 | Buy | 626,043 | $6.70 | 4,194,488 |
|
Cullinan Therapeutics Inc CGEM
"Common stock, $0.0001 par value per share (""Common Stock"")"
|
2025-10-08 | Buy | 556,300 | $6.46 | 3,593,698 |
|
Passage Bio Inc PASG
Common Stock
|
2025-07-24 | Buy | 66,423 | $5.71 | 379,275 |
|
Passage Bio Inc PASG
Common Stock
|
2025-07-23 | Buy | 49,302 | $5.74 | 282,993 |
|
Passage Bio Inc PASG
"Common stock, $0.0001 par value per share (""Common Stock"")"
|
2025-07-22 | Buy | 13,123 | $5.44 | 71,389 |
|
TScan Therapeutics Inc TCRX
Common Stock
|
2025-05-20 | Buy | 1,200,000 | $1.20 | 1,440,000 |
|
TScan Therapeutics Inc TCRX
"Common stock, $0.0001 par value per share (""Common Stock"")"
|
2025-05-19 | Buy | 1,388,794 | $1.20 | 1,666,553 |
|
Passage Bio Inc PASG
Common stock, $0.0001 par value per share
|
2024-12-27 | Buy | 373,645 | $0.65 | 242,869 |
|
TScan Therapeutics Inc TCRX
Pre-funded Warrant (right to buy) · derivative
|
2024-12-26 | Buy | 7,500,000 | $4.00 | 30,000,000 |
|
TScan Therapeutics Inc TCRX
Common Stock
|
2024-12-13 | Buy | 100,000 | $2.90 | 290,000 |
| showing 20 of 29 most recent transactions | |||||